申请人:Chu Xin-Jie
公开号:US20060041146A1
公开(公告)日:2006-02-23
The present invention relates to compounds of the formula
which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
本发明涉及一类化合物,其结构式如下:
这些化合物在治疗由MEK过度活跃引起的疾病方面具有用途。因此,这些化合物在治疗诸如癌症、认知和CNS疾病以及炎症/自身免疫疾病等疾病方面是有用的。